138251000202108: Tralokinumab (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament (substance)\Monoclonal antibody\Tralokinumab (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Tralokinumab (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Tralokinumab (substance)

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Tralokinumab (substance)
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Tralokinumab (substance)
\Biological substance\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Tralokinumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

5266530014 Tralokinumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

5266531013 Tralokinumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Tralokinumab (substance)	Is a	Monoclonal antibody	true	Inferred relationship	Some
Tralokinumab (substance)	Is a	Interleukin receptor antagonist	false	Inferred relationship	Some
Tralokinumab (substance)	Has disposition (attribute)	Interleukin receptor antagonist (disposition)	false	Inferred relationship	Some
Tralokinumab (substance)	Is a	Substance with interleukin-13 receptor antagonist mechanism of action (substance)	true	Inferred relationship	Some
Tralokinumab (substance)	Has disposition (attribute)	Interleukin 13 receptor antagonist (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely tralokinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Tralokinumab (substance)	Inferred relationship	Some	1
Product containing precisely tralokinumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Tralokinumab (substance)	Inferred relationship	Some	1
Tralokinumab-containing product in parenteral dose form	Has active ingredient	True	Tralokinumab (substance)	Inferred relationship	Some	1
Tralokinumab-containing product	Has active ingredient	True	Tralokinumab (substance)	Inferred relationship	Some	1
Product containing only tralokinumab (medicinal product)	Has active ingredient	True	Tralokinumab (substance)	Inferred relationship	Some	1
Product containing only tralokinumab in parenteral dose form (medicinal product form)	Has active ingredient	True	Tralokinumab (substance)	Inferred relationship	Some	1

This concept is not in any reference sets